Esperion Therapeutis.Inc. buy Wolf_of_WS
Summary
This prediction ended on 01.10.23 with a price of €0.94. With a performance of -7.27%, the BUY prediction by Wolf_of_WS finished with a loss. Wolf_of_WS has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
According to Wolf_of_WS what are the pros and cons of Esperion Therapeutis.Inc. for the foreseeable future?
Pros
Cons
Comments by Wolf_of_WS for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
In the thread Trading Esperion Therapeutis.Inc.
Stopped prediction by Wolf_of_WS for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
02.03.25
02.03.26
15.03.25
Esperion Therapeutis.Inc.
23.08.23
23.08.24
30.08.23
Esperion Therapeutis.Inc.
10.05.23
10.05.24
15.05.23
Esperion Therapeutis.Inc.
11.04.23
11.04.24
15.04.23


